gene therapy

FDA clears Pfizer to restart Duchenne gene therapy trial, with new safeguards
BioPharma Dive
Thu, 04/28/22 - 10:56 am
Pfizer
gene therapy
Duchenne Muscular Dystrophy
clinical trial
FDA
Sio Gene could be a canary in the coalmine for gene therapy
EP Vantage
Thu, 04/28/22 - 10:42 am
Sio Gene
Axovant
gene therapy
Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy
Fierce Biotech
Wed, 04/27/22 - 10:51 pm
AviadoBio
demential
Zolgensma
AVB-101
gene therapy
Undeterred by gene therapy’s struggles, a startup launches into a downturn
BioPharma Dive
Tue, 04/26/22 - 10:29 am
gene therapy
funding
startups
Apertura Gene Therapies
Astellas, Tmunity, Underscore Rocky Terrain of CAR-T and Gene Therapies
BioSpace
Mon, 04/25/22 - 10:38 pm
Astellas
Tmunity
CAR-T
gene therapy
myotubular myopathy
Astellas takes $170m charge as it drops DMD gene therapies
Pharmaforum
Fri, 04/22/22 - 10:48 am
Astellas
gene therapy
Duchenne Muscular Dystrophy
earnings
Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals
BioSpace
Wed, 04/6/22 - 07:37 pm
Takeda
Evozyne
gene therapy
Rare Diseases
Hunting for next big eye disease drug, Regeneron gets deeper into gene therapies with ViGeneron pact
Fierce Biotech
Wed, 04/6/22 - 12:18 pm
Regeneron
gene therapy
ViGeneron
retinal disease
FDA releases draft guidance for cell and gene therapies
Biopharma Reporter
Wed, 04/6/22 - 11:35 am
FDA
regulatory
cell therapy
gene therapy
CAR-T
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021
Fierce Biotech
Tue, 04/5/22 - 11:41 pm
regenerative medicine
gene editing
gene therapy
Big Pharma
Intellia Therapeutics
Novartis manufacturing facility in North Carolina gets FDA all-clear to produce, ship gene therapies
Endpoints
Tue, 04/5/22 - 11:33 pm
Novartis
gene therapy
North Carolina
FDA
Zolgensma
Genprex pairs gene therapy delivery tech with Keytruda in lung cancer trial
Fierce Pharma
Tue, 04/5/22 - 11:50 am
Genprex
gene therapy
Merck Keytruda
non-small cell lung cancer
drug delivery
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Fierce Biotech
Tue, 04/5/22 - 11:13 am
Takeda
gene therapy
Evozyne
R&D
Bayer reloads Leaps with €1.3 billion to step up investments in biotech innovation
MedCity News
Mon, 04/4/22 - 10:19 am
Bayer
Leaps by Bayer
innovation
artificial intelligence
gene therapy
cell therapy
funding
2 gene editing biotechs team up to improve on delivery with $45 upfront
Fierce Biotech
Thu, 03/31/22 - 11:20 pm
gene editing
gene therapy
Myeloid Therapeutics
Prime Medicine
As biotech retreats, gene therapy companies retrench and redraw plans
BioPharma Dive
Thu, 03/24/22 - 08:29 pm
biotech
gene therapy
layoffs
R&D
Bluebird Bio
Allogene
uniQure
Dermatology biotech Krystal settles lawsuit from former partner as it prepares first FDA pitch
Endpoints
Wed, 03/16/22 - 10:31 am
Krystal Biotech
dermatology
legal
PeriphaGen
gene therapy
Passage Bio to cut jobs in latest biotech restructuring
BioPharma Dive
Tue, 03/15/22 - 11:31 pm
Passage Bio
restructuring
gene therapy
layoffs
New Data Reinforces Impact of Novartis' Gene Therapy on SMA
BioSpace
Mon, 03/14/22 - 10:46 am
Novartis
gene therapy
spinal muscular atrophy
Zolgensma
Selecta back in phase 1 gene therapy saddle after clinical hold lift, plans to reboot 'expeditiously'
Fierce Biotech
Thu, 03/10/22 - 10:27 pm
Selecta Biosciences
gene therapy
rare disease
methylmalonic acidemia
clinical trials

Pages